Monday March 22, 2010 3:46 AM ET
SmartMoney
Share Price ($): 
58.94
Price Change: 
0.00 (0.00%)
Last 10 Quotes
What is this?
OSIP 
(OSI Pharmaceuticals Inc.)
Exchange: NASD     Industry: Biotechnology
Last Trade 4:00 PM ET 3/19/2010
Click Here Click Here
Chart for OSIP
After-Hours Trading:
Last Trade:NA
Price:NA
Volume:NA
Breaking News
4:54 PM  3/19/2010   Astellas Changes 2 Nominees For Election To OSI Pharma Board
6:38 PM  3/17/2010   Roche CEO Touts Pipeline, Remains Open To More Deals
3:28 PM  3/15/2010   2nd UPDATE: OSI Rejects $3.5 Billion Astellas Offer, Talks With Others
1:56 PM  3/15/2010   UPDATE: OSI Rejects $3.5 Billion Astellas Offer, Talking With Others
9:13 AM  3/15/2010   OSI Pharma Rejects Astellas $3.5 Billion Takeover Offer
10:30 PM  3/2/2010   ASIA MARKETS: Japanese Drug Makers Put Up A Fight
1:56 PM  3/2/2010   CORRECT: Astellas Begins $3.5 Billion Tender Offer For OSI Pharma
Stories & Blogs: Around the Web
3/20/2010  The Unusual Suspects (ADBE, AIXG, GME, HAS, BBY, CIEN, LGF, ORCL, OSIP, PALM, SOMX, TEVA, TIF, CSCO, PFE, AMGN, RIMM) (24/7 Wall St)
3/19/2010  BioHealth Business Daily (APPA, GENZ, GENT, MRK, OSIP, OXGN, SOMX, THRX, CLDX) (24/7 Wall St)
3/18/2010  BioHealth Business Daily (APPA, ARIA, MDVN, OSIP, SOMX, TEVA) (24/7 Wall St)
3/16/2010  Corporate Watch (WSJ.com)
3/16/2010  Astellas to Press on With OSI Bid (WSJ.com)
3/15/2010  OSI Pharmaceuticals Rejects Offer from Astellas (Fox Business)
3/15/2010  Drug stocks up as OSI rejects $3.5 billion bid (MarketWatch.com)
3/12/2010  Maybe April will be a better month for the drug giant. (The Motley Fool)
Earnings & Forecast
Most Recent Quarter ($)Same Quarter Last Year ($)% Change
EPS, Pro Forma 0.48 0.44 9.09
EPS, GAAP 0.43 5.47 -92.14
Consensus Estimate 0.43 0.48 -10.42
Trailing 12 MonthsYear-Earlier Period% Change
EPS, Pro Forma 1.62 1.50 8.00
EPS, GAAP 1.29 7.24 -82.18
Consensus Estimate 1.43 NA NA
Key Statistics
OSIPIndustry Average
P/E (TTM) 45.69 59.70
P/E (Forward) 37.07 2.80
PEG Ratio 2.75 0.14
Price/Sales 8.32 4.38
Beta 0.55 0.62
Advertisements
View Overview for: